Brief: Medtronic Says FDA Grants Breakthrough Device Designation For Sphere-9 Catheter For VT
25/04/2026 17:34
April 25 (Reuters) - Medtronic PLC MDT.N: MEDTRONIC ANNOUNCES KEY AFFERA™ CLINICAL STUDY MILESTONES FOR SPHERE-9™ AND SPHERE-360™ CATHETERS AS GLOBAL ADOPTION CONTINUES MEDTRONIC PLC - FDA GRANTS BREAKTHROUGH DEVICE DESIGNATION FOR SPHERE-9 CATHETER FOR VT Source text: ID:nPnc1Kxfda Further company coverage: MDT.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medtronic
See all newsStreet View: Medtronic moves from 'show me' story to 'trust the setup' story
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway
Medtronic climbs after Q4 results beat estimates